ImmuPharma PLC (IMM) Stock Price & News

All values in GBP	2025 ж. қыр.	2025 ж. жел.	2026 ж. нау.	2026 ж. мау.
Revenue	-	-	-	-
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	328,10 м.	328,10 м.	295,52 м.	295,52 м.
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	298,97 м.	298,97 м.	217,49 м.	217,49 м.
Operating expense	652,16 м.	652,16 м.	534,07 м.	534,07 м.
Total operating expenses	652,16 м.	652,16 м.	534,07 м.	534,07 м.
Operating income	-652,16 м.	-652,16 м.	-534,07 м.	-534,07 м.
Other non operating income	184,07 м.	184,07 м.	-	-
EBT including unusual items	-111,44 м.	-111,44 м.	-2,35 млн	-2,35 млн
EBT excluding unusual items	-111,44 м.	-111,44 м.	-2,35 млн	-2,35 млн
Income tax expense	-127,05 м.	-127,05 м.	-	-
Effective tax rate	114,00%	114,00%	-	-
Other operating expenses	-1,34 мың	-1,34 мың	-	-
Net income	15,61 мың	15,61 мың	-2,35 млн	-2,35 млн
Net profit margin	-	-	-	-
Earnings per share	-	-	-	-
Interest and investment income	367,37 м.	367,37 м.	1,78 мың	1,78 мың
Interest expense	-9,14 мың	-9,14 мың	-1,82 млн	-1,82 млн
Net interest expenses	358,23 м.	358,23 м.	-1,82 млн	-1,82 млн
Depreciation and amortization charges	-	-	-	-
EBITDA	-648,78 м.	-648,78 м.	-533,82 м.	-533,82 м.
Gain or loss from assets sale	-	-	-	-

Ask anything